Volume 7, Issue 4 (Autumn 2019)                   Iran J Health Sci 2019, 7(4): 1-8 | Back to browse issues page


XML Print


Kharazmi University, Tehran, Iran , shahabi.zahra8817@yahoo.com
Abstract:   (2959 Views)
Background and purpose: Deficits of retrospective memory (RetM) and prospective memory (ProM), which are two primary components of episodic memory, have been reported in prior studies in HIV-infected individuals. The present study aimed to further elucidate the characteristics of prospective and retrospective memory complaints in HIV-infected individuals.
Materials and Methods: We recruited 50 HIV-uninfected individuals from the general community, and 67 HIV-infected people who were under the treatment of antiretroviral therapy (ART) in Imam Khomeini Hospital of Tehran, Iran in 2016. Analysis of variance (ANOVA) was used to inspect the differences between HIV-infected and seronegative volunteers.
Results: The results of ANOVA showed that HIV-infected individuals had more complaints of in long-delayed ProM (p=0.049), short-delayed RetM (p=0.016), and long-delayed RetM (p=0.009) than seronegative volunteers. No difference was observed in the complaints of short-delayed ProM between HIV-infected and the seronegative volunteers (p=0.921). The results of paired sample t-test also revealed that ProM complaints did not differ with RetM complaints among HIV-infected individuals (p=0.55), but ProM complaints were more frequent than RetM complaints among seronegative volunteers (p<0.001).
Conclusion: Through understanding the characteristics of ProM/RetM complaints in HIV-infected individuals, we will be able to provide appropriate rehabilitation programs which correctly target their ProM/RetM deficits.
 
Full-Text [PDF 546 kb]   (1045 Downloads)    
Type of Study: Review Article | Subject: Pharmacy

References
1. Cannon MJ, Dollard SC, Black JB, Edlin BR, Hannah C, Hogan SE, et al. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. Aids. 2003;17(2):215-22.
2. González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nature Reviews Immunology. 2005;5(1):69-81. [DOI:10.1038/nri1527]
3. Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS and Behavior. 2010;14(6):1213-26. [DOI:10.1007/s10461-010-9684-1]
4. Au A, Cheng C, Chan I, Leung P, Li P, Heaton RK. Subjective memory complaints, mood, and memory deficits among HIV/AIDS patients in Hong Kong. Journal of Clinical and Experimental Neuropsychology. 2008;30(3):338-48.
5. Maki P, Cohen M, Weber K, Little D, Fornelli D, Rubin L, et al. Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study. Neurology. 2009;72(19):1661-8. [DOI:10.1212/WNL.0b013e3181a55f65]
6. Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology. 2008;22(1):110. [DOI:10.1037/0894-4105.22.1.110]
7. Martin EM, Nixon H, Pitrak DL, Weddington W, Rains NA, Nunnally G, et al. Characteristics of prospective memory deficits in HIV-seropositive substancedependent individuals: Preliminary observations. Journal of Clinical and Experimental Neuropsychology. 2007;29(5):496-504. [DOI:10.1080/13803390600800970]
8. Morgan EE, Weber E, Rooney AS, Grant I, Woods SP, Group HNRP. Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND). Journal of clinical and experimental neuropsychology. 2012;34(4):416-27. [DOI:10.1080/13803395.2012.654764]
9. Carey CL, Paul Woods S, Rippeth JD, Heaton RK, Grant I, Group HNRC. Prospective memory in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology. 2006;28(4):536-48. [DOI:10.1080/13803390590949494]
10. Woods SP, Carey CL, Moran LM, Dawson MS, Letendre SL, Grant I, et al. Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Archives of Clinical Neuropsychology. 2007;22(2):187-95. [DOI:10.1016/S0887-6177(07)00067-4]
11. Crawford J, Smith G, Maylor E, Della Sala S, Logie R. The Prospective and Retrospective Memory Questionnaire (PRMQ): Normative data and latent structure in a large non-clinical sample. Memory. 2003;11(3):261-75. [DOI:10.1080/09658210244000027]
12. Zare H, Alipur A, Mostafaie A. Standardization and Validity Retrospective Memory-Prospective. Quarterly Journal of Social Cognition 2014; 3(1):45-56. [In Persian]
13. Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIVassociated neurocognitive disorders. Neuropsychology review. 2009;19(2):152-68. [DOI:10.1007/s11065-009-9102-5]
14. Ances BM, Hammoud DA. Neuroimaging of HIV associated neurocognitive disorders (HAND). Current Opinion in HIV and AIDS. 2014;9(6):545. [DOI:10.1097/COH.0000000000000112]
15. Uttl B, Kibreab M. Self-report measures of prospective memory are reliable but not valid. Canadian Journal of Experimental Psychology/Revue canadienne de psychologie expérimentale. 2011;65(1):57. [DOI:10.1037/a0022843]
16. Ghodrati S, Shahabinezhad Z, Seyedalinaghi S, Sadeghi N, Baesi K, Voltarelli F. Cognitive, Immunologic, Virologic, Functional, and Demographic Predictors of Health-related Quality of Life in People Living with HIV. Journal of International Translational Medicine. 2018;6(3):136-40.
17. Farhoudi B, Alipour A, Ghodrati S, Seyedalinaghi S, Zanganeh M, Mohraz M. Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study. Archives of Clinical Infectious Diseases. 2018; 13(2):1-6.
18. Woods SP, Moran LM, Carey CL, Dawson MS, Iudicello JE, Gibson S, et al. Prospective memory in HIV infection: Is "remembering to remember" a unique predictor of self-reported medication management? Archives of Clinical Neuropsychology. 2008;23(3):257-70. [DOI:10.1016/j.acn.2007.12.006]
19. Emamzadeh-Fard S, E Fard S, SeyedAlinaghi S, Paydary K. Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: a review. Infectious Disorders-Drug Targets (Formerly Current Drug Targets- Infectious Disorders). 2012;12(5):346-56. [DOI:10.2174/187152612804142251]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.